Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $857.70 | 19 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $445.71 | 4 | $0 (2021) |
| BOSTON SCIENTIFIC CORPORATION | $134.98 | 2 | $0 (2021) |
| Pharmacyclics LLC, An AbbVie Company | $62.88 | 3 | $0 (2023) |
| Myriad Genetic Laboratories, Inc. | $60.77 | 3 | $0 (2022) |
| Bayer HealthCare Pharmaceuticals Inc. | $45.56 | 2 | $0 (2022) |
| Janssen Biotech, Inc. | $31.19 | 2 | $0 (2021) |
| Palette Life Sciences, Inc. | $28.77 | 1 | $0 (2022) |
| TOLMAR Pharmaceuticals, Inc. | $24.52 | 1 | $0 (2022) |
| Avadel Specialty Pharmaceuticals, LLC | $23.32 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $62.88 | 3 | Pharmacyclics LLC, An AbbVie Company ($62.88) |
| 2022 | $127.05 | 5 | Myriad Genetic Laboratories, Inc. ($49.38) |
| 2021 | $644.45 | 10 | Dendreon Pharmaceuticals LLC ($445.71) |
| 2018 | $23.32 | 1 | Avadel Specialty Pharmaceuticals, LLC ($23.32) |
All Payment Transactions
19 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/30/2023 | Pharmacyclics LLC, An AbbVie Company | EPKINLY (Drug) | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: ONCOLOGY | ||||||
| 07/11/2023 | Pharmacyclics LLC, An AbbVie Company | EPKINLY (Drug) | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: ONCOLOGY | ||||||
| 04/04/2023 | Pharmacyclics LLC, An AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: ONCOLOGY | ||||||
| 12/15/2022 | Palette Life Sciences, Inc. | — | Food and Beverage | In-kind items and services | $28.77 | General |
| 11/11/2022 | Bayer HealthCare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: Oncology | ||||||
| 09/26/2022 | TOLMAR Pharmaceuticals, Inc. | ELIGARD (Drug) | Food and Beverage | In-kind items and services | $24.52 | General |
| Category: Prostate Cancer | ||||||
| 09/20/2022 | Myriad Genetic Laboratories, Inc. | Prolaris (Device) | Food and Beverage | Cash or cash equivalent | $28.35 | General |
| Category: Gene Expression Analysis Oncology | ||||||
| 09/20/2022 | Myriad Genetic Laboratories, Inc. | Prolaris (Device) | Food and Beverage | Cash or cash equivalent | $21.03 | General |
| Category: Gene Expression Analysis Oncology | ||||||
| 10/28/2021 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $153.92 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 10/19/2021 | BOSTON SCIENTIFIC CORPORATION | GENERAL ONCOLOGY (Device) | Food and Beverage | In-kind items and services | $116.86 | General |
| Category: PAIN MANAGEMENT | ||||||
| 10/19/2021 | BOSTON SCIENTIFIC CORPORATION | SPACEOAR VUE (Device) | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: PAIN MANAGEMENT | ||||||
| 10/19/2021 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Oncology | ||||||
| 10/12/2021 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $81.51 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 09/22/2021 | Bayer HealthCare Pharmaceuticals Inc. | Xofigo (Drug) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: Oncology | ||||||
| 09/22/2021 | Myriad Genetic Laboratories, Inc. | Prolaris (Device) | Food and Beverage | Cash or cash equivalent | $11.39 | General |
| Category: Gene Expression Analysis Oncology | ||||||
| 07/22/2021 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $147.07 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 06/29/2021 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $63.21 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 06/16/2021 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: Oncology | ||||||
| 04/04/2018 | Avadel Specialty Pharmaceuticals, LLC | Noctiva (Drug) | Food and Beverage | In-kind items and services | $23.32 | General |
| Category: Urology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 45 | 101 | $90,132 | $17,349 |
| 2022 | 6 | 282 | 1,156 | $1.0M | $197,553 |
| 2021 | 9 | 306 | 1,484 | $1.4M | $298,826 |
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G6015 | Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | Office | 2023 | 15 | 43 | $71,181 | $13,453 | 18.9% |
| G6002 | Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy | Office | 2023 | 15 | 43 | $15,367 | $2,768 | 18.0% |
| 77336 | Continuing radiation therapy consultation per week | Office | 2023 | 15 | 15 | $3,583 | $1,128 | 31.5% |
| G6015 | Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | Office | 2022 | 70 | 429 | $710,158 | $137,937 | 19.4% |
| 77014 | Ct guidance for insertion of radiation therapy fields | Office | 2022 | 71 | 428 | $216,568 | $28,796 | 13.3% |
| 77427 | Radiation treatment management, 5 treatment sessions | Office | 2022 | 41 | 95 | $44,417 | $15,363 | 34.6% |
| 77336 | Continuing radiation therapy consultation per week | Office | 2022 | 68 | 172 | $41,087 | $12,517 | 30.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 15 | 15 | $3,975 | $1,552 | 39.1% |
| 77334 | Design and construction of complex radiation treatment device | Office | 2022 | 17 | 17 | $8,021 | $1,387 | 17.3% |
| G6015 | Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | Office | 2021 | 59 | 557 | $922,047 | $188,595 | 20.5% |
| 77014 | Ct scan guidance for insertion of radiation therapy fields | Office | 2021 | 59 | 550 | $278,300 | $39,143 | 14.1% |
| 77427 | Radiation treatment management, 5 treatments | Office | 2021 | 57 | 203 | $94,913 | $33,184 | 35.0% |
| 77301 | Management of modulation radiotherapy planning | Office | 2021 | 11 | 11 | $61,204 | $18,555 | 30.3% |
| 77336 | Radiation therapy consultation per week | Office | 2021 | 46 | 89 | $21,260 | $6,478 | 30.5% |
| 77338 | Design and construction of device for radiation therapy | Office | 2021 | 11 | 11 | $13,343 | $4,566 | 34.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 26 | 26 | $6,890 | $3,781 | 54.9% |
| 77263 | Management of radiation therapy, complex | Office | 2021 | 16 | 16 | $6,448 | $2,312 | 35.9% |
| 77334 | Radiation treatment devices, design and construction, complex | Office | 2021 | 21 | 21 | $9,908 | $2,212 | 22.3% |
About Dr. Victor Risch, MD
Dr. Victor Risch, MD is a Radiation Oncology healthcare provider based in Allentown, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/21/2005. The National Provider Identifier (NPI) number assigned to this provider is 1811970296.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Victor Risch, MD has received a total of $857.70 in payments from pharmaceutical and medical device companies, with $62.88 received in 2023. These payments were reported across 19 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($857.70).
As a Medicare-enrolled provider, Risch has provided services to 633 Medicare beneficiaries, totaling 2,741 services with total Medicare billing of $513,729. Data is available for 3 years (2021–2023), covering 18 distinct procedure/service records.
Practice Information
- Specialty Radiation Oncology
- Location Allentown, AL
- Active Since 11/21/2005
- Last Updated 08/23/2007
- Taxonomy Code 2085R0001X
- Entity Type Individual
- NPI Number 1811970296
Products in Payments
- PROVENGE (Drug) $445.71
- GENERAL ONCOLOGY (Device) $116.86
- Prolaris (Device) $60.77
- EPKINLY (Drug) $40.47
- ERLEADA (Drug) $31.19
- ELIGARD (Drug) $24.52
- Nubeqa (Drug) $24.38
- Noctiva (Drug) $23.32
- IMBRUVICA (Drug) $22.41
- Xofigo (Drug) $21.18
- SPACEOAR VUE (Device) $18.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Radiation Oncology Doctors in Allentown
Sean Quinlan-Davidson, M.d, M.D
Radiation Oncology — Payments: $1,326
Dr. Charles Andrews, Md, MD
Radiation Oncology — Payments: $1,270
Robert Prosnitz, Md, MD
Radiation Oncology — Payments: $917.31
Dr. Dennis Sopka, M.d, M.D
Radiation Oncology — Payments: $879.25
Alyson Mcintosh, Md, MD
Radiation Oncology — Payments: $874.98
Dr. Hasan Danish, M.d, M.D
Radiation Oncology — Payments: $337.86